Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1987 | 12-1986 | 12-1985 | 12-1984 | 12-1983 | |
| Gross Profit | 8,455 | 2,719 | -2,767 | -1,900 | -911 |
| Operating Expenses | 11,045 | 4,636 | 0 | 0 | 0 |
| Operating Income | -11,045 | -4,636 | N/A | N/A | N/A |
| Pre-tax Income | -11,045 | -4,636 | 0 | 0 | 0 |
| Net Income Continuous | -11,045 | -4,636 | N/A | N/A | N/A |
| Net Income | $-11,045 | $-4,636 | $N/A | $N/A | $N/A |
| EBITDA(a) | $-9,708 | $-4,343 | $264 | $N/A | $N/A |